image
Merus N.V. MRUS
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 46.58
-6.2 %
$ 3.19 B
Market Cap
-11.56
P/E
INCOME STATEMENT
43.9 M REVENUE
5.68%
Growth Rates
1Year 5.68%
3Years 13.64%
5Years 4.09%
7Years 47.75%
10Years 66.97%
-157 M OPERATING INCOME
2.18%
Growth Rates
1Year 2.18%
3Years -27.30%
5Years -28.64%
7Years -27.17%
10Years -27.60%
-155 M NET INCOME
-18.10%
Growth Rates
1Year -18.10%
3Years -21.91%
5Years -41.04%
7Years -17.65%
10Years -27.47%
EFFICIENCY
Earnings Waterfall Merus N.V.
image
Revenue 43.9 M
Cost Of Revenue 127 M
Gross Profit -83.5 M
Operating Expenses 200 M
Operating Income -157 M
Other Expenses -1.61 M
Net Income -155 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 43.9 41.6 49.1 29.9 31.1 36.0 14.9 2.9 1.4 0.9 0.3
GROSS PROFIT
Cost Of Revenue 127.4 12.0 86.3 57.3 49.6 0.2 0 1.5 0 18.6 10.1
Gross Profit (83.5) 29.6 (37.2) (27.4) (18.5) 35.7 14.9 1.4 1.4 (17.7) (9.9)
OPERATING INCOME
Operating Expenses 200.5 201.6 139.1 105.8 89.8 80.4 67.2 32.0 26.6 3.5 3.8
Selling, General and Administrative Expenses 59.8 52.2 40.9 35.8 34.1 11.9 16.4 4.5 0.8 3.9 3.9
Research and Development Expenses 140.7 149.4 98.2 70.0 55.7 53.5 40.9 20.0 17.9 0 0
Operating Income (156.5) (160.0) (90.0) (75.9) (58.7) (44.4) (52.3) (29.1) (25.2) (21.2) (13.7)
PRE-TAX INCOME
Interest Income Expense 0 2.7 0.1 0 0 4.58 K 13.1 20.7 0.2 47.4 K 75.9 K
Total Other Income 4.8 19.2 12.5 (22.9) (2.7) 15.4 (35.1) (20.3) (0.2) 13.4 K 2.76 K
Pre-Tax Income (151.7) (130.2) (66.6) (85.0) (55.0) (27.4) (87.4) (49.7) (25.3) (21.2) (13.7)
NET INCOME
Tax Provision 3.2 1.0 0.2 0.5 0.2 0.4 0.3 (0.2) 54.7 K 60.8 K 73.2 K
Net Income (154.9) (131.2) (66.8) (85.5) (55.2) (27.8) (87.7) (49.7) (25.3) (21.2) (13.7)
EPS 3 2.92 1.73 2.92 2.28 1.25 4.57 3.75 1.65 1.37 0.89